ClinConnect ClinConnect Logo
Search / Trial NCT03165383

The Analgesic Efficacy of Ultrasound Guided Transversus Abdominal Plane Block After Abdominal Cancer Surgeries

Launched by RAJIV GANDHI CANCER INSTITUTE & RESEARCH CENTER, INDIA · May 23, 2017

Trial Information

Current as of May 09, 2025

Completed

Keywords

Transverse Abdominis Plane (Tap) Block Patient Control Analgesia (Pca)

ClinConnect Summary

Adult patients of both sexes undergoing major lower abdominal cancer surgeries were enrolled in the study. After obtaining written informed consent from all the patients, they were randomly allotted to either Study (TAP) Group or Control group. Standard general anesthesia with endotracheal intubation was performed in all the patients. Preoperatively all patients received information about Visual Analogue Scale (VAS) for Pain Score from 1 to 10 depending on intensity of pain and about the use of Patient Controlled Analgesia (PCA) Pump. After the end of surgery and before extubation bilateral...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients belonging to American Society of Anesthesiologist (ASA) Physical Status I to III, for Open lower abdominal major onco surgeries more than 2 hours duration.
  • Exclusion Criteria:
  • Patient refusal to participate in the study, allergy to local anesthetics, coagulopathy, local skin infection at the site of TAP Block.

About Rajiv Gandhi Cancer Institute & Research Center, India

The Rajiv Gandhi Cancer Institute & Research Center (RGCI&RC) in India is a leading institution dedicated to the comprehensive care and advanced research in oncology. Renowned for its commitment to providing cutting-edge cancer treatment, RGCI&RC combines clinical excellence with innovative research initiatives aimed at improving patient outcomes. The institute boasts state-of-the-art facilities and a multidisciplinary team of experts who collaborate to conduct clinical trials, explore new therapies, and enhance the understanding of cancer. RGCI&RC's mission is to advance cancer care through rigorous scientific inquiry and compassionate patient management, positioning itself as a pivotal player in the global fight against cancer.

Locations

Patients applied

0 patients applied

Trial Officials

Anita Kulkarni, MD

Principal Investigator

Rajiv Gandhi Cancer Institute and Research Centre , Delhi , India 110085

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials